logo
  • About us
    • Reig Jofre in brief
    • Strategic pillars
    • Company history
    • Locations
  • Products
    • Product categories
    • Pharmaceutical Technologies
      • Antibiotics
      • Injectable products
      • Others
    • Specialty Products
      • Dermatology
      • Osteoarticular
      • Women’s Health
      • Pediatrics
    • Consumer healthcare
    • Healthcare professionals
      and consumers corner
  • R&D
    • R&D
    • Innovation in Collaboration
    • Pipeline
    • Joint projects
  • Services
    • CDMO services
    • CMO services
  • Investors
    • Information note
    • General information
    • Inside information
    • Other relevant information
    • Former relevant facts
    • Financial information
    • Corporate governance
    • General shareholders’ meetings
    • The share
    • Analysts covering the stock
    • Presentations
    • Webcasts
  • News
    • News and repository
    • Reig Jofre in the media (ES)
    • Subscription center
  • Social Responsibility
  • Contact
    • Contact form
    • Work with us
    • Subscription center
  • |
  • ES
  • EN

News

Transparency withour stakeholders

  • Show all
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011

26 September 2023

REIG JOFRE appointed Alex Sanfeliu as the new Global Head of Pharmaceutical Technologies business unit

27 July 2023

REIG JOFRE submits press release on the results of the second quarter of 2023

30 June 2023

Reig Jofre and Zendal appointed by the EU to ensure vaccine production capacity in Europe in case of future health emergencies

25 May 2023

REIG JOFRE joins FARMAMUNDI’s Humanitarian Action and Emergency Fund

28 February 2023

Reig Jofre convenes its 2023 General Shareholders´ Meeting

28 February 2023

REIG JOFRE submits results note on fourth quarter of 2022

13 December 2022

REIG JOFRE has successfully completed the co-development of TRIFERTY-ATM®, a food supplement that contributes to male fertility

8 November 2022

REIG JOFRE launches a medicinal nail lacquer for onychomycosis with Ciclotech® the new patented trans-ungueal release technology

2 November 2022

REIG JOFRE submits press release on the global license agreement reached by Syna Therapeutics

28 October 2022

REIG JOFRE submits results note on third quarter of 2022

7 September 2022

FORTÉ PHARMA, REIG JOFRE’s brand of food supplements launches its E-commerce in China

26 July 2022

Reig Jofre submits results note on second quarter of 2022

25 July 2022

Reig Jofre informs on the start date of the trading of the new shares within its scrip dividend

12 July 2022

Reig Jofre informs on the bonus-shares capital increase and the new shares to be issued for its scrip dividend

14 June 2022

Execution of the scrip dividend

9 June 2022

Reig Jofre informs on the Scrip Dividend Conditions

23 May 2022

Reig Jofre launches Regenail® topical solution for structural nail alterations

28 February 2022

Reig Jofre submits results note on fourth quarter of 2021

15 November 2021

Bioglan and Stada partner to increase capacity to meet rising demand for Parkinson’s treatment

29 October 2021

Reig Jofre submits results note on third quarter of 2021

  • 1
  • 2
  • 3
  • …
  • 17

Legal advice – Online store access for employees – RJF connected

© 2020 Laboratorio Reig Jofre

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsRead MoreAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
SAVE & ACCEPT

Privacy Preference Center

Privacy Preferences